For a large percentage of men with prostate cancer, the tumor may be so slow-growing that doctors advise a "watch-and-wait" approach instead of active treatment.
May 30, 2024
0
8
Risk-adjusted screening strategies for prostate cancer should help to ensure that fewer men are tested unnecessarily often. According to the experts, this can reduce over-diagnosis and over-treatment, which can cause more ...
May 16, 2024
0
1
Treating prostate cancer with immunotherapy is currently difficult to do. But results from a first in-human Phase I trial using a chimeric antigen receptor (CAR) T cell therapy developed by researchers from City of Hope, ...
Jun 12, 2024
0
0
Two genes working in tandem play a critical role in shaping the identity and behavior of prostate cancer cells and their response to treatment, UT Southwestern Medical Center researchers report.
Jun 5, 2024
0
0
The partners of patients with prostate cancer grapple with their own quality-of-life issues that impact their sexual well-being, a new study shows. Using the first questionnaire of its kind, the authors uncovered key challenges ...
May 20, 2024
0
0
Treatment resistance caused by cancer cell plasticity constitutes a major challenge in the treatment of prostate cancer. A recent study from the University of Eastern Finland Institute of Biomedicine published in Nucleic ...
Jun 3, 2024
0
1
From an economic perspective, first-line prostate-specific antigen (PSA) testing is favored over biparametric magnetic resonance imaging (bpMRI) for prostate cancer screening, mainly due to false-positive results and overdiagnosis, ...
Jun 4, 2024
0
0
Fibroblast activation protein (FAP)-targeted radioligand therapy is safe and effective for treating patients with progressive metastatic tumors, specifically advanced sarcomas, according to research presented at the 2024 ...
Jun 10, 2024
0
0
Some women who experience menopause early—before age 40—have an increased risk of developing breast and ovarian cancer, according to research being presented at ENDO 2024, the Endocrine Society's annual meeting in Boston, ...
Jun 3, 2024
0
0
Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and prostate cancer-specific mortality, according to a study published online ...
Jun 7, 2024
0
0
